This study aims to assess the impact of medication efficacy on determinants of psychiatric illness among participants with diabetes mellitus. Psychiatric disorders, such as depression and anxiety, are prevalent among individuals with diabetes and can negatively impact disease management and overall well-being. However, the role of medication efficacy in mitigating psychiatric symptoms in this population remains underexplored. This comprehensive assessment investigates the relationship between medication efficacy and determinants of psychiatric illness, including symptom severity, quality of life, and psychosocial functioning, among participants with diabetes mellitus. Participants' medication regimens, psychiatric symptoms, and diabetes-related factors are evaluated through validated assessment tools and clinical measurements. Statistical analyses are performed to examine the association between medication efficacy and psychiatric illness determinants, while controlling for relevant confounding variables. Findings from this study have the potential to enhance our understanding of the impact of medication efficacy on psychiatric symptoms in individuals with diabetes, thereby informing tailored treatment approaches and improving overall patient outcomes.

Medication efficacy, psychiatric illness, diabetes mellitus

Balhara Y. Diabetes and psychiatric disorders. Indian J Endocrinol Metab 2011;15(4):274.

2. Sun N, Lou P, Shang Y, Zhang P, Wang J, Chang G et al. Prevalence and determinants of depressive and anxiety symptoms in adults with type 2 diabetes in China: a cross-sectional study. BMJ Open 2016;6(8):1-8.

Subramaniam M, Chong S, Pek E. Diabetes Mellitus and Impaired Glucose Tolerance in Patients with Schizophrenia. Can J Psychiatry 2003;48(5):345-47.

4. Huang C, Wang S, Lee M, Chiu H. Prevalence and incidence of mental illness in diabetes: A national population-based cohort study. Diabetes Res Clin Practice 2011;93(1):106-14.

5. Agarwal A, Jadhav P, Deshmukh Y. Prescribing pattern and efficacy of anti -diabetic drugs in maintaining optimal glycemic levels in diabetic patients. J Basic Clin Pharm 2014;5(3):79.

6. Fourrier A, Gasquet I, Allicar M, Bouhassira M, Lépine J, Bégaud B. Patterns of neuroleptic drug prescription: a national cross - sectional survey of a random sample of French psychiatrists. Br J Pharmacol 2001;49(1):80-86.

7. Surwit R, Schneider M, Feinglos M.Stress and Diabetes Mellitus. Diabetes Care 1992;15(10):1413-22.

8. Elamoshy R, Bird Y, Thorpe L, Moraros J. Risk of Depression and Suicidality among Diabetic Patients: A Systematic Review and Meta - Analysis. J Clin Med 2018;7(11):445.

9. Khandelwal D, Bahety P, Agarwal G, Dutta D, Kalra S, Taparia P et al. Occurrence and predictors of depression and poor quality of life among patients with Type -2 diabetes: A Northern India perspective. Indian J Endocrinol Metab 2017;21(4):564.

10. AlBekairy A, AbuRuz S, Alsabani B, Alshehri A, Aldebasi T, Alkatheri A et al. Exploring Factors Associated with Depression and Anxiety among Hospitalized Patients with Type 2 Diabetes Mellitus. Medical Principles and Practice 2017;26(6):547-53.